ArticleWorld journal of urology2012

XPA-210: a new proliferation marker determines locally advanced prostate cancer and is a predictor of biochemical recurrence.

Stefan Aufderklamm et al.PubMed ↗Publisher ↗

No numbers read from the abstract.